Kezar Life Sciences Inc Net Income per Employee (KZR), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Kezar Life Sciences Inc   (NASDAQ: KZR)
 

Kezar Life Sciences Inc Net Income per Employee

KZR's Quarterly Results, Trends, Rankings, Statistics
Kezar Life Sciences Inc recorded a cumulative net loss of $-45 million during 12 month ending in the first quarter 2026.
The Healthcare sector has seen employees of 412 other companies achieving higher income per employee. While Kezar Life Sciences Inc 's total ranking has deteriorated compared to the previous quarter from 3136 to 4094.


What is Income per Employee Ratio?






KZR Net Income per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -5,025,889 -6,225,889 -6,856,111 -7,865,667 -8,737,111
KZR's Total Ranking # 4094 # 3136 # 3481 # 2965 # 2933
Seq. Net Income Change - - - - -


KZR Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 413
Healthcare Sector # 860
Overall Market # 4094

Net Income per Employee Statistics
High Average Low
$ -752,778 $ -6,364,248 $ -11,318,889
(Jun 30 2018)   (Dec 31 2023)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026


Date modified: 2026-08-30T14:58:34+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.